Search results
Wall Street Bulls Look Optimistic About Dick's (DKS): Should You Buy?
Zacks via Yahoo Finance· 2 days agoThe average brokerage recommendation (ABR) for Dick's (DKS) is equivalent to a Buy. The overly...
Is It Worth Investing in Enterprise Products (EPD) Based on Wall Street's Bullish Views?
Zacks via Yahoo Finance· 2 days agoThe average brokerage recommendation (ABR) for Enterprise Products (EPD) is equivalent to a Buy. The...
Jabil Inc. (NYSE:JBL) Receives Average Recommendation of “Buy” from Brokerages
ETF DAILY NEWS· 10 hours agoShares of Jabil Inc. (NYSE:JBL – Get Free Report) have earned a consensus rating of “Buy” from the seven research firms that are currently covering the stock, Marketbeat Ratings reports. One ...
Margin Debt Is Rising. It’s a Sign Some Investors Are Amping Up Risk.
Barrons.com· 3 days agoBEST PRACTICES Margin debt, the sum total investors have borrowed from their brokerage firms to buy...
How Tony Accardo Uses Compass to Run Real Estate in The Beach Cities
USA Today· 18 hours agoTony Accardo is a California native and the founder of AREA (Accardo Real Estate Associates), a real...
UBS upgrades C.H. Robinson stock, cites operational improvements and EPS growth By Investing.com
Investing.com· 1 day agoOn Thursday, UBS adjusted its stance on C.H. Robinson Worldwide (NASDAQ:CHRW), upgrading the...
Wall Street Bulls Look Optimistic About Sunoco LP: Should You Buy? - Sunoco (NYSE:SUN)
Benzinga· 2 days agoLet's take a look at what these Wall Street heavyweights have to say about Sunoco LP SUN before we...
China securities regulator seeks to ease market panic over delisting risks
Reuters via Yahoo Finance· 23 hours agoThe "survival of the fittest" mechanism is gradually taking shape but in the short term, there will...
Brokers Suggest Investing in Howmet: Read This Before Placing a Bet - Howmet Aerospace (NYSE:HWM)
Benzinga· 2 days agoLet's take a look at what these Wall Street heavyweights have to say about Howmet HWM before we...
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $66.29 Consensus Target Price from Analysts
ETF DAILY NEWS· 11 hours agoJanux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight brokerages that are presently covering the ...